Angiopoietin Like 3, Angiopoietin 5, ANGPT5, ANG-5, Angiopoietin-Related Protein 3 , Angiopoietin-Like Protein 3, Angiopoietin-Like 3, Angiopoietin-5, FHBL2, ANL3.
Angiopoietin Like 3, Angiopoietin 5, ANGPT5, ANG-5, Angiopoietin-Related Protein 3 , Angiopoietin-Like Protein 3, Angiopoietin-Like 3, Angiopoietin-5, FHBL2, ANL3.
ANGPTL3 antibody was purified by protein-A affinity chromatography.
PAT23D8AT.
Anti-human ANGPTL3 mAb, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with a recombinant human ANGPTL3 protein 243-460 amino acids purified from E. coli.
Mouse IgG2a heavy chain and κ light chain.
Mouse Anti-Human Angiopoietin-Like Protein 3 (ANGPTL3) Clone PAT23D8AT is a monoclonal antibody specifically designed to target and bind to human ANGPTL3. This antibody is produced in mice and is widely used in various research applications, including Western Blot (WB), Enzyme-Linked Immunosorbent Assay (ELISA), Immunocytochemistry (ICC), and Immunofluorescence (IF) .
ANGPTL3 is a member of the angiopoietin-like protein family, which plays a crucial role in lipid metabolism and angiogenesis. It is primarily expressed in the liver and has been shown to regulate plasma lipid levels by inhibiting lipoprotein lipase (LPL) activity. Elevated levels of ANGPTL3 are associated with hyperlipidemia and an increased risk of cardiovascular diseases .
The PAT23D8AT clone is derived from a single B-cell clone of a mouse immunized with human ANGPTL3. The monoclonal antibody is produced using hybridoma technology, where the B-cells are fused with myeloma cells to create a hybrid cell line capable of producing large quantities of the antibody. This process ensures the specificity and consistency of the antibody .